Cargando…
Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal
Rebamipide was initially developed and approved for use in treating gastric ulcers and lesions associated with gastritis. Discovery of its ability to increase gastric mucin led to investigations of its effect on ocular surface mucin and the subsequent development for use in dry eye patients. Investi...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051796/ https://www.ncbi.nlm.nih.gov/pubmed/24940041 http://dx.doi.org/10.2147/OPTH.S40798 |